Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ishares Msci Spain ETF (EWP) vs Illumina, Inc. (ILMN) Price & Performance

Ishares Msci Spain ETFTrade
Illumina, Inc.Trade

Price performance (Past 24H)

Key statistics

Ishares Msci Spain ETF vs Illumina, Inc. — how do they compare? Ishares Msci Spain ETF trades at $62.65, while Illumina, Inc. trades at $193.06 (market cap $28.96B). The key difference: Ishares Msci Spain ETF is trading nearer its 52-week high, Illumina, Inc. nearer its low. Which is the better fit depends on your goals.

EWPILMN
Sector
Broad Market / FactorHealth
52-Week High
$62.66$205.10
52-Week Low
$47.02$91.00
Market Cap
$28.96B
Enterprise Value
$30.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ishares Msci Spain ETF

EWP is trading at $62.66, up 0.58% with a bullish technical signal driven by strong moving average support. The stock shows mixed momentum with overbought RSI readings but positive ADX trend strength. Recent corporate actions include a $0.92 dividend scheduled for June 2026. European market sentiment remains influenced by ECB policy decisions and energy price volatility.

The stock's outlook balances technical strength against fundamental data gaps. European economic resilience and potential short-squeeze dynamics offer upside, while overbought conditions and geopolitical risks present near-term headwinds. Dividend income provides additional shareholder value, though comprehensive financial metrics are needed for full fundamental assessment.

Illumina, Inc.

Illumina (ILMN) trades at $187.96, down 2.97% on the day, but maintains strong fundamental momentum with three consecutive quarterly earnings beats. The stock shows robust profitability with 66.38% gross margins and 18.34% net income margins, though technical indicators suggest near-term bearish pressure. Recent institutional buying activity and positive analyst coverage (51% buy ratings) support the stock's long-term growth narrative in the genomics sector.

The outlook remains positive with a consensus price target of $201.58 representing 7% upside potential. Key catalysts include continued NovaSeq X adoption and AI partnerships, while risks involve competitive pressures and execution challenges in achieving projected revenue growth. The company's turnaround from net losses to $850M profit in 2025 demonstrates improved operational efficiency.

Returns comparison

Trailing returns across standard periods

About Ishares Msci Spain ETF

EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.

Read more on EWP

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN